Growth & Performance
Research on peptides for growth hormone and performance. Research profiles focused on growth hormone signaling, lean mass, and performance biology.
9
Profiles
0
Blends
1
Cart-enabled
Browsing
Growth & Performance
Provider-reviewed
Licensed 503A pharmacy
Shop first
Injectable
Vial-based peptide products and blends.
Tesamorelin
15mg vial
GHRH analog studied for visceral-fat reduction; the molecule was approved as Egrifta
IGF-1 LR3
1mg vial
Extended-action insulin-like growth factor for muscle growth
Hexarelin
5mg vial
Potent GH secretagogue with cardioprotective benefits
Sermorelin
5mg vial
Bioidentical GHRH analog for natural growth hormone pulsatility
GHRP-2
5mg vial
Potent growth hormone secretagogue via ghrelin receptor
GHRP-6
5mg vial
Growth hormone secretagogue with appetite-stimulating properties
CJC-1295 DAC
2mg vial
Long-acting GHRH analog with Drug Affinity Complex for sustained GH elevation
Follistatin 344
1mg vial
Myostatin inhibitor studied for enhanced muscle growth
IGF-1 DES (1-3)
1mg vial
Truncated IGF-1 with 10x binding potency for localized muscle growth
Source reviewed
How to compare product options
Shoppers comparing FormBlends GLP-1 programs, peptide bundles, and research profiles need a direct answer on fit first, then the evidence, timeline, and provider-review details that change the decision.
Answer who qualifies, what it costs, what forms exist, common side effects, and which alternatives to compare.
Put the practical answer near the top before the commercial call to action.
Link to dosing, safety, cost, and comparison guides that support the decision.
Questions this page should answer clearly
- How do I choose between FormBlends GLP-1 programs and peptide bundles?
- Start with the plain answer, then add the caveat that changes the decision: cost, coverage, safety, provider oversight, pharmacy source, or whether the claim can be verified.
- Which FormBlends products can I add to cart versus which require provider review?
- Start with the plain answer, then add the caveat that changes the decision: cost, coverage, safety, provider oversight, pharmacy source, or whether the claim can be verified.
- How do semaglutide and tirzepatide programs compare on results and timeline?
- Start with the plain answer, then add the caveat that changes the decision: cost, coverage, safety, provider oversight, pharmacy source, or whether the claim can be verified.
- What evidence and safety review backs each FormBlends product?
- Start with the plain answer, then add the caveat that changes the decision: cost, coverage, safety, provider oversight, pharmacy source, or whether the claim can be verified.
Finder facts for search and AI answers
What this product finder answers
Catalog scope
9 growth & performance profiles
Research on peptides for growth hormone and performance
Clinical access
0 GLP-1 program profiles in this view
GLP-1 treatment paths require licensed-provider review for eligibility, contraindications, dosing, and side-effect management.
Research status
0 watchlist or research-only profiles in this view
Research/watchlist pages should not be treated as ordinary patient access pages.
Decision role
Compare goal fit, evidence strength, mechanism, timeline, and next step
The finder should route users into the right product page rather than making every product look equivalent.